133 related articles for article (PubMed ID: 37949371)
1. Efficacy of octenidine- and chlorhexidine-based wash-mitts against Candida albicans and Candida auris - a comparative study.
Gugsch F; Tan CK; Oh DY; Paßvogel L; Steinhauer K
J Hosp Infect; 2024 Jan; 143():91-96. PubMed ID: 37949371
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the susceptibility of Candida auris and Candida albicans to chemical disinfectants using European Standards EN 13624 and EN 16615.
Müller P; Tan CK; Ißleib U; Paßvogel L; Eilts B; Steinhauer K
J Hosp Infect; 2020 Aug; 105(4):648-656. PubMed ID: 32454076
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of octenidine against emerging echinocandin-, azole- and multidrug-resistant Candida albicans and Candida glabrata.
Spettel K; Bumberger D; Camp I; Kriz R; Willinger B
J Glob Antimicrob Resist; 2022 Jun; 29():23-28. PubMed ID: 35134551
[TBL] [Abstract][Full Text] [Related]
4. EFFECT of daily antiseptic body wash with octenidine on nosocomial primary bacteraemia and nosocomial multidrug-resistant organisms in intensive care units: design of a multicentre, cluster-randomised, double-blind, cross-over study.
Meißner A; Hasenclever D; Brosteanu O; Chaberny IF
BMJ Open; 2017 Nov; 7(11):e016251. PubMed ID: 29122787
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of the yeasticidal efficacy of povidone-iodine-based commercial antiseptic solutions against Candida auris.
Chesnay A; Bailly É; Desoubeaux G
J Mycol Med; 2021 Dec; 31(4):101173. PubMed ID: 34271481
[TBL] [Abstract][Full Text] [Related]
6. Yeasticidal activity of chemical disinfectants and antiseptics against Candida auris.
Moore G; Schelenz S; Borman AM; Johnson EM; Brown CS
J Hosp Infect; 2017 Dec; 97(4):371-375. PubMed ID: 28865738
[TBL] [Abstract][Full Text] [Related]
7. The comparative efficacy of antiseptics against Candida auris biofilms.
Kean R; McKloud E; Townsend EM; Sherry L; Delaney C; Jones BL; Williams C; Ramage G
Int J Antimicrob Agents; 2018 Nov; 52(5):673-677. PubMed ID: 29775686
[TBL] [Abstract][Full Text] [Related]
8. Effect of antiseptic bathing with chlorhexidine or octenidine on central line-associated bloodstream infections in intensive care patients: a cluster-randomized controlled trial.
Denkel LA; Schwab F; Clausmeyer J; Behnke M; Golembus J; Wolke S; Gastmeier P; Geffers C
Clin Microbiol Infect; 2022 Jun; 28(6):825-831. PubMed ID: 35031487
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of biofilm disrupters against Candida auris and other Candida species in monomicrobial and polymicrobial biofilms.
Cox CA; Manavathu EK; Wakade S; Myntti M; Vazquez JA
Mycoses; 2024 Jan; 67(1):e13684. PubMed ID: 38214428
[TBL] [Abstract][Full Text] [Related]
10. Chlorhexidine and octenidine susceptibility of bacterial isolates from clinical samples in a three-armed cluster randomised decolonisation trial.
Denkel LA; Kramer TS; Schwab F; Golembus J; Wolke S; Gastmeier P; Geffers C
PLoS One; 2022; 17(12):e0278569. PubMed ID: 36516147
[TBL] [Abstract][Full Text] [Related]
11. Antifungal activity of octenidine dihydrochloride and ultraviolet-C light against multidrug-resistant Candida auris.
Ponnachan P; Vinod V; Pullanhi U; Varma P; Singh S; Biswas R; Kumar A
J Hosp Infect; 2019 May; 102(1):120-124. PubMed ID: 30261239
[TBL] [Abstract][Full Text] [Related]
12. Standardized comparison of antiseptic efficacy of triclosan, PVP-iodine, octenidine dihydrochloride, polyhexanide and chlorhexidine digluconate.
Koburger T; Hübner NO; Braun M; Siebert J; Kramer A
J Antimicrob Chemother; 2010 Aug; 65(8):1712-9. PubMed ID: 20551215
[TBL] [Abstract][Full Text] [Related]
13. Antifungal efficacy of natural antiseptic products against Candida auris.
Wu WG; Luk KS; Hung MF; Tsang WY; Lee KP; Lam BH; Cheng KL; Cheung WS; Tang HL; To WK
Med Mycol; 2024 Jun; ():. PubMed ID: 38936838
[TBL] [Abstract][Full Text] [Related]
14. Central-line associated bloodstream infections in intensive care units before and after implementation of daily antiseptic bathing with chlorhexidine or octenidine: a post-hoc analysis of a cluster-randomised controlled trial.
Denkel LA; Schwab F; Clausmeyer J; Behnke M; Golembus J; Wolke S; Gastmeier P; Geffers C;
Antimicrob Resist Infect Control; 2023 Jun; 12(1):55. PubMed ID: 37270604
[TBL] [Abstract][Full Text] [Related]
15. Comparative antifungal efficacy of light-activated disinfection and octenidine hydrochloride with contemporary endodontic irrigants.
Eldeniz AU; Guneser MB; Akbulut MB
Lasers Med Sci; 2015 Feb; 30(2):669-75. PubMed ID: 23884903
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial efficacy of 3 oral antiseptics containing octenidine, polyhexamethylene biguanide, or Citroxx: can chlorhexidine be replaced?
Rohrer N; Widmer AF; Waltimo T; Kulik EM; Weiger R; Filipuzzi-Jenny E; Walter C
Infect Control Hosp Epidemiol; 2010 Jul; 31(7):733-9. PubMed ID: 20518635
[TBL] [Abstract][Full Text] [Related]
17.
Arendrup MC; Jørgensen KM; Hare RK; Chowdhary A
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844005
[TBL] [Abstract][Full Text] [Related]
18. In vitro antifungal activity of Cinnamomum zeylanicum bark and leaf essential oils against Candida albicans and Candida auris.
Tran HNH; Graham L; Adukwu EC
Appl Microbiol Biotechnol; 2020 Oct; 104(20):8911-8924. PubMed ID: 32880694
[TBL] [Abstract][Full Text] [Related]
19. Residual antimicrobial effect of chlorhexidine digluconate and octenidine dihydrochloride on reconstructed human epidermis.
Müller G; Langer J; Siebert J; Kramer A
Skin Pharmacol Physiol; 2014; 27(1):1-8. PubMed ID: 23887383
[TBL] [Abstract][Full Text] [Related]
20. Proposed phase 2/ step 2 in-vitro test on basis of EN 14561 for standardised testing of the wound antiseptics PVP-iodine, chlorhexidine digluconate, polihexanide and octenidine dihydrochloride.
Schedler K; Assadian O; Brautferger U; Müller G; Koburger T; Classen S; Kramer A
BMC Infect Dis; 2017 Feb; 17(1):143. PubMed ID: 28193164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
